Bioactive Compounds
-
B5818 GSK2838232Summary: HIV-1 maturation inhibitor -
B5846 Radotinib(IY-5511)Target: PDGFR|Bcr-AblSummary: Bcr-Abl tyrosine kinase inhibitor -
B5870 ELR510444Summary: Novel microtubule disruptor -
B5979 CCT251545Summary: Orally bioavailable and potent WNT signaling inhibitor -
A1049 Angiotensin 1/2 (5-7)Summary: Vasoconstrictor -
C6618 2,6-Dibromophenol -
C6645 BCA -
B6171 CC-223Summary: mTOR inhibitor, orally bioavailable -
B6184 BI-9564Summary: BRD9/7 specific inhibitor -
B7824 ML390Summary: human DHODH inhibitor

